Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

被引:0
|
作者
Arrospide, A. [1 ,2 ]
Sagardui, M. G. [1 ]
Larizgoitia, I. [1 ]
Iturralde, A. [1 ,3 ]
Moreda, A. [1 ]
Mar, J. [2 ,4 ,5 ]
机构
[1] Minist Hlth Basque Govt, Donostia San Sebastian Kalea 1, Vitoria 01010, Spain
[2] Biodonostia Hlth Res Inst, Econ Evaluat Chron Dis Res Grp, San Sebastian, Spain
[3] Osakidetza Basque Hlth Serv, Directorate Gen, Vitoria, Spain
[4] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Arrasate Mondragon, Spain
[5] Kronikgune Inst Hlth Serv Res, Baracaldo, Spain
关键词
COVID-19; Vaccine; Vaccine booster; Effectiveness; Hospital admissions; Omicron; IMPACT;
D O I
10.1016/j.vaccine.2023.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4274 / 4279
页数:6
相关论文
共 50 条
  • [31] Teachers' Digital Competence in Basque Country during the COVID-19 pandemic
    Portillo-Berasaluce, Javier
    Ronnero, Ainara
    Tejada, Eneko
    REVISTA LATINOAMERICANA DE TECNOLOGIA EDUCATIVA-RELATEC, 2022, 21 (01): : 57 - 73
  • [32] COVID-19 BOOSTER VACCINE RELATED DERMATITIS: A CASE STUDY
    Sheikh, A.
    Godil, S.
    Pham, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP272 - NP272
  • [33] COVID-19 vaccine booster dose effectiveness among health workers: systematic review & meta-analysis
    Bartolucci, L.
    Damiani, G.
    Pascucci, D.
    Marafon, D. Pires
    Laurenti, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [34] Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
    Park, Seon Kyeong
    Choe, Young June
    Jang, Eun Jung
    Kim, Ryu Kyung
    Lee, Sang-Won
    Kwon, Geun-Yong
    Shin, Jeeyeon
    Choi, Sang-Yoon
    Jeong, Mi Jin
    Park, Young-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (19)
  • [35] Effectiveness of monovalent COVID-19 booster/ additional vaccine doses in the United States
    Layton, J. Bradley
    Peetluk, Lauren S.
    Wong, Hui-Lee
    Jiao, Yixin
    Ogilvie, Rachel
    Miller, Michael
    Glazier-Essalmi, Alicynne
    Parambi, Ron J.
    Song, Jennifer
    Martinez, Xabier Garcia de Albeniz
    Lloyd, Patricia C.
    Lo, An-Chi
    Kawai, Alison Tse
    Weatherby, Lisa
    Bell, Elizabeth J.
    Yang, Grace
    Amend, Kandace L.
    Gruber, Joann F.
    Clarke, Tainya C.
    Forshee, Richard A.
    Anderson, Steven A.
    Wernecke, Michael
    Matuska, Kathryn
    Chillarige, Yoganand
    Anthony, Mary S.
    Seeger, John D.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 608 - 608
  • [36] Takotsubo Cardiomyopathy Following COVID-19 Vaccine Booster Dose: A Case Report
    Reza, Rezaur Rahman
    Parajuli, Aalok
    Padullaparthi, Tripura
    Aloori, Swetha
    Baddam, Anusha
    Parajuli, Aakriti
    Karnati, Susannah shiny
    Nasir, Hira
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [37] Mothers' Impressions and Beliefs About Taking a Booster Dose for COVID-19 Vaccine During Pregnancy and Lactation
    Taybeh, Esra' O.
    Alsharedeh, Rawan
    Hamadneh, Shereen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [38] Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States
    Layton, J. Bradley
    Peetluk, Lauren
    Wong, Hui Lee
    Jiao, Yixin
    Djibo, Djeneba Audrey
    Bui, Christine
    Lloyd, Patricia C.
    Gruber, Joann F.
    Miller, Michael
    Ogilvie, Rachel P.
    Deng, Jie
    Parambi, Ron
    Song, Jennifer
    Weatherby, Lisa B.
    Lo, An-Chi
    Matuska, Kathryn
    Wernecke, Michael
    Clarke, Tainya C.
    Cho, Sylvia
    Bell, Elizabeth J.
    Seeger, John D.
    Yang, Grace Wenya
    Illei, Dora
    Forshee, Richard A.
    Anderson, Steven A.
    McMahill-Walraven, Cheryl N.
    Chillarige, Yoganand
    Amend, Kandace L.
    Anthony, Mary S.
    Shoaibi, Azadeh
    VACCINE: X, 2024, 16
  • [39] Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
    Zhou, Hui Jun
    Pan, Lei
    Shi, Hui
    Luo, Ji Wei
    Wang, Pei
    Porter, Hannah K.
    Bi, Ye
    Li, Minghui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
    Wong, Li Ping
    Alias, Haridah
    Siaw, Yan-Li
    Muslimin, Mustakiza
    Lai, Lee Lee
    Lin, Yulan
    Hu, Zhijian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)